ESR1 and breast carcinoma: In breast cancer, studies showed that DEPTOR expression is repressed by EMT programs in estrogen receptor α negative cells, and also decreased in cancer stem cells or tumor tissues of patients with aggressive breast cancers, however it is essential for the growth and Chemo-resistance of tumor cells [16, 28].